BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that its medical devices division, Designer Diagnostics, has developed a rapid diagnostic test kit for Tuberculosis and will be conducting clinical trials at National Jewish Hospital in Denver, Colorado.
